← Eichor
Condition: Randomized Study Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Randomized Study

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency
Phase 4 · 1 location(s) · Prove pharm · NCT06054880A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Can
Phase 3 · 49 location(s) · Dizal (Jiangsu) Pharmaceutical Co., Ltd. · NCT07182682S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
Phase 4 · 34 location(s) · Fudan University · NCT04790305A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Phase 3 · 42 location(s) · Cascade Pharmaceuticals, Inc · NCT07282353Liposomal Bupivacaine and Bupivacaine for TTMPB in Median Sternotomy
NA · 1 location(s) · Tongji Hospital · NCT06646172ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
NA · 1 location(s) · Sunnybrook Health Sciences Centre · NCT04335994Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Pa
Phase 3 · 60 location(s) · ECOG-ACRIN Cancer Research Group · NCT05863195Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
Phase 1 · 2 location(s) · HTIC, Inc · NCT07449572A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chro
Phase 2 · 1 location(s) · Institute of Medicinal Biotechnology, Chinese Academy of Med · NCT07496177A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Phase 3 · 174 location(s) · Pfizer · NCT07282665Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT04231565The Effects of 5G Radiation on Skin
NA · 1 location(s) · Prof. Olivier Gaide, MD-PhD · NCT05933954Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Affiliated Cancer Hospital & Institute of Guangzhou Medical · NCT04437329Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
Phase 2 · 12 location(s) · Alphyn Biologics · NCT06855745Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07494565A Food-Effect Study of CX11 in Healthy Participants
Phase 1 · 1 location(s) · Vincentage Pharma Co., Ltd · NCT07349381Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With La
NA · 1 location(s) · Huashan Hospital · NCT06211712Effects of Single Sodium Bicarbonate Supplementation on National-Level Finswimming Performance
NA · 1 location(s) · Palacky University · NCT07135934A Study to Verify if the Surgery for the Proximal Femur Fracture Can be Improved With the Help of a Navigation System
NA · 1 location(s) · Christian Candrian · NCT04494672Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)
Phase 2/Phase 3 · 50 location(s) · Airway Therapeutics, Inc. · NCT06897839A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight
Phase 1 · 1 location(s) · Suzhou Alphamab Co., Ltd. · NCT06547775A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic
Phase 1 · 26 location(s) · R-Pharm · NCT07543744A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Phase 2 · 17 location(s) · Crystalys Therapeutics · NCT07535034Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery
Phase 1 · 1 location(s) · CSPC Ouyi Pharmaceutical Co., Ltd. · NCT07519109Implementation and Evaluation of a Fear of Cancer Recurrence Screening, Referral and Management Program
NA · 2 location(s) · The University of Hong Kong · NCT06181344A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
Phase 2 · 70 location(s) · Intra-Cellular Therapies, Inc. · NCT06651567A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young Adults
Phase 1 · 1 location(s) · Vaxcyte, Inc. · NCT07616934A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Phase 3 · 106 location(s) · Verastem, Inc. · NCT06072781A Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries
Phase 1/Phase 2 · 1 location(s) · University of Manitoba · NCT04893863
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.